Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Minneapolis, Minnesota 55404


Purpose:

This study is designed to investigate the safety and tolerability of AIR001 Inhalation Solution when administered under conditions of hypoxia and to identify dose levels of drug resulting in a reduction in pulmonary arterial pressure under these hypoxic conditions.


Criteria:

Inclusion Criteria: - Normal male and female volunteers - Age 18-55 - Demonstrate a rise in pulmonary artery pressure to low inspired oxygen concentration (a normal response to breathing a low level of oxygen) Exclusion Criteria: - Significant medical illnesses - Risk factors for pulmonary hypertension - G6PD or Cytochrome B5 Reductase deficiencies - History of any form of altitude sickness - Current prescription or over the counter medication use


NCT ID:

NCT00814645


Primary Contact:

Principal Investigator
Suzanne K Swan, M.D.
Davita Clinical Research


Backup Contact:

N/A


Location Contact:

Minneapolis, Minnesota 55404
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.